Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
March-2018 Volume 17 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2018 Volume 17 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

CLC-2 is a positive modulator of oligodendrocyte precursor cell differentiation and myelination

  • Authors:
    • Xiaolin Hou
    • Rui Zhang
    • Junyan Wang
    • Yunhong Li
    • Fan Li
    • Yan Zhang
    • Xiaomin Zheng
    • Ying Shen
    • Yin Wang
    • Liang Zhou
  • View Affiliations / Copyright

    Affiliations: Department of Neurology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China, Ningxia Key Laboratory of Cerebrocranial Diseases, Basic Medical School of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China, Department of Neurobiology, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, P.R. China
    Copyright: © Hou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4515-4523
    |
    Published online on: January 17, 2018
       https://doi.org/10.3892/mmr.2018.8439
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Oligodendrocytes (OLs) are myelin-forming cells that are present within the central nervous system. Impaired oligodendrocyte precursor cell (OPC) differentiation into mature OLs is a major cause of demyelination diseases. Therefore, identifying the underlying molecular mechanisms of OPC differentiation is crucial to understand the processes of myelination and demyelination. It has been acknowledged that various extrinsic and intrinsic factors are involved in the control of OPC differentiation; however, the function of ion channels, particularly the voltage‑gated chloride channel (CLC), in OPC differentiation and myelination are not fully understood. The present study demonstrated that CLC‑2 may be a positive modulator of OPC differentiation and myelination. Western blotting results revealed that CLC‑2 was expressed in both OPCs and OLs. Furthermore, CLC‑2 currents (ICLC‑2) were recorded in both types of cells. The inhibition of ICLC‑2 by GaTx2, a blocker of CLC‑2, was demonstrated to be higher in OPCs compared with OLs, indicating that CLC‑2 may serve a role in OL differentiation. The results of western blotting and immunofluorescence staining also demonstrated that the expression levels of myelin basic protein were reduced following GaTx2 treatment, indicating that the differentiation of OPCs into OLs was inhibited following CLC‑2 inhibition. In addition, following western blot analysis, it was also demonstrated that the protein expression of the myelin proteins yin yang 1, myelin regulatory factor, Smad‑interacting protein 1 and sex‑determining region Y‑box 10 were regulated by CLC‑2 inhibition. Taken together, the results of the present study indicate that CLC‑2 may be a positive regulator of OPC differentiation and able to contribute to myelin formation and repair in myelin‑associated diseases by controlling the number and open state of CLC-2 channels.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Tauheed AM, Ayo JO and Kawu MU: Regulation of oligodendrocyte differentiation: Insights and approaches for the management of neurodegenerative disease. Pathophysiology. 23:203–210. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Mi S, Lee X, Hu Y, Ji B, Shao Z, Yang W, Huang G, Walus L, Rhodes K, Gong BJ, et al: Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelinatin. Nat Med. 17:816–821. 2011. View Article : Google Scholar : PubMed/NCBI

3 

Wolswijk G: Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain. 123:105–115. 2000. View Article : Google Scholar : PubMed/NCBI

4 

Billiards SS, Haynes RL, Folkerth RD, Borenstein NS, Trachtenberg FL, Rowitch DH, Ligon KL, Volpe JJ and Kinney HC: Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol. 18:153–163. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Boespflug-Tanguy O, Labauge P, Fogli A and Vaurs-Barriere C: Genes involved in leukodystrophies: A glance at glial functions. Curr Neurol Neurosci Rep. 8:217–229. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Miller RH: Regulation of oligodendrocyte development in the vertebrate CNS. Prog Neurobiol. 67:451–467. 2002. View Article : Google Scholar : PubMed/NCBI

7 

Emery B: Regulation of oligodendrocyte differentiation and myelination. Science. 330:779–782. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Wang S, Sdrulla AD, DiSibio G, Bush G, Nofziger D, Hicks C, Weinmaster G and Barres BA: Notch receptor activation inhibits oligodendrocyte differentiation. Neuron. 21:63–75. 1998. View Article : Google Scholar : PubMed/NCBI

9 

Charles P, Hernandez MP, Stankoff B, Aigrot MS, Colin C, Rougon G, Zalc B and Lubetzki C: Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc Natl Acad Sci USA. 97:pp. 7585–7590. 2000; View Article : Google Scholar : PubMed/NCBI

10 

Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, et al: LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci. 8:745–751. 2005. View Article : Google Scholar : PubMed/NCBI

11 

Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ and Stiles CD: bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science. 306:2111–2115. 2004. View Article : Google Scholar : PubMed/NCBI

12 

Fu H, Qi Y, Tan M, Cai J, Takebayashi H, Nakafuku M, Richardson W and Qiu M: Dual origin of spinal oligodendrocyte progenitors and evidence for the cooperative role of Olig2 and Nkx2.2 in the control of oligodendrocyte differentiation. Development. 129:681–693. 2002.PubMed/NCBI

13 

Emery B, Agalliu D, Cahoy JD, Watkins TA, Dugas JC, Mulinyawe SB, Ibrahim A, Ligon KL, Rowitch DH and Barres BA: Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell. 138:172–185. 2009. View Article : Google Scholar : PubMed/NCBI

14 

Liu Z, Hu X, Cai J, Liu B, Peng X, Wegner M and Qiu M: Induction of oligodendrocyte differentiation by Olig2 and Sox10: Evidence for reciprocal interactions and dosage-dependent mechanisms. Dev Biol. 302:683–693. 2007. View Article : Google Scholar : PubMed/NCBI

15 

He Y, Dupree J, Wang J, Sandoval J, Li J, Liu H, Shi Y, Nave KA and Casaccia-Bonnefil P: The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron. 55:217–230. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Wegner M: A matter of identity: Transcriptional control in oligodendrocytes. J Mol Neurosci. 35:3–12. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ and Rowitch DH: Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 23:1571–1585. 2009. View Article : Google Scholar : PubMed/NCBI

18 

Zhou L, Shao CY, Xu SM, Ma J, Xie YJ, Zhou L, Teng P, Wang Y, Qiu M and Shen Y: GSK3β promotes the differentiation of oligodendrocyte precursor cells via β-catenin-mediated transcriptional regulation. Mol Neurobiol. 50:507–519. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Williamson AV, Compston DA and Randall AD: Analysis of the ion channel complement of the rat oligodendrocyte progenitor in a commonly studied in vitro preparation. Eur J Neurosci. 9:706–720. 1997. View Article : Google Scholar : PubMed/NCBI

20 

Kraus V, Srivastava R, Kalluri SR, Seidel U, Schuelke M, Schimmel M, Rostasy K, Leiz S, Hosie S, Grummel V and Hemmer B: Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease. Neurology. 82:470–473. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Srivastava R, Aslam M, Kalluri SR, Schirmer L, Buck D, Tackenberg B, Rothhammer V, Chan A, Gold R, Berthele A, et al: Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med. 367:115–123. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Kirischuk S, Scherer J, Möller T, Verkhratsky A and Kettenmann H: Subcellular heterogeneity of voltage-gated Ca2+ channels in cells of the oligodendrocyte lineage. Glia. 13:1–12. 1995. View Article : Google Scholar : PubMed/NCBI

23 

Zhao B, Quan H, Ma T, Tian Y, Cai Q and Li H: 4,4′-Diisothiocyanostilbene-2,2′-disulfonic acid (DIDS) ameliorates ischemia-hypoxia-induced white matter damage in neonatal rats through inhibition of the voltage-gated chloride channel ClC-2. Int J Mol Sci. 16:10457–10469. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Yang Z, Watanabe M and Nishiyama A: Optimization of oligodendrocyte progenitor cell culture method for enhanced survival. J Neurosci Methods. 149:50–56. 2005. View Article : Google Scholar : PubMed/NCBI

25 

Wang Z, Wang YN, Sun CL, Yang D, Su LD, Xie YJ, Zhou L, Wang Y and Shen Y: C-terminal domain of ICA69 interacts with PICK1 and acts on trafficking of PICK1-PKCα complex and cerebellar plasticity. PLoS One. 8:e838622013. View Article : Google Scholar : PubMed/NCBI

26 

Lalor PA, Mapp PI, Hall PA and Revell PA: Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol Int. 7:183–186. 1987. View Article : Google Scholar : PubMed/NCBI

27 

Thiemann A, Gründer S, Pusch M and Jentsch TJ: A chloride channel widely expressed in epithelial and non-epithelial cells. Nature. 356:57–60. 1992. View Article : Google Scholar : PubMed/NCBI

28 

Sík A, Smith RL and Freund TF: Distribution of chloride channel-2-immunoreactive neuronal and astrocytic processes in the hippocampus. Neuroscience. 101:51–65. 2000. View Article : Google Scholar : PubMed/NCBI

29 

Weng Q, Chen Y, Wang H, Xu X, Yang B, He Q, Shou W, Chen Y, Higashi Y, Van den Berghe V, et al: Dual-mode modulation of Smad signaling by Smad-interacting protein Sip1 is required for myelination in the central nervous system. Neuron. 73:713–728. 2012. View Article : Google Scholar : PubMed/NCBI

30 

Jentsch TJ, Stein V, Weinreich F and Zdebik AA: Molecular structure and physiological function of chloride channels. Physiol Rev. 82:503–568. 2002. View Article : Google Scholar : PubMed/NCBI

31 

Olsen ML, Schade S, Lyons SA, Amaral MD and Sontheimer H: Expression of voltage-gated chloride channels in human glioma cells. J Neurosci. 23:5572–5582. 2003.PubMed/NCBI

32 

Levison SW, Chuang C, Abramson BJ and Goldman JE: The migrational patterns and developmental fates of glial precursors in the rat subventricular zone are temporally regulated. Development. 119:611–622. 1993.PubMed/NCBI

33 

Amberger VR, Avellana-Adalid V, Hensel T, Baron-Van Evercooren A and Schwab ME: Oligodendrocyte-type 2 astrocyte progenitors use ametalloendoprotease to spread and migrate on CNS myelin. Eur J Neurosci. 9:151–162. 1997. View Article : Google Scholar : PubMed/NCBI

34 

Huang H, Zhao XF, Zheng K and Qiu M: Regulation of the timing of oligodendrocyte differentiation: Mechanisms and perspectives. Neurosci Bull. 29:155–164. 2013. View Article : Google Scholar : PubMed/NCBI

35 

Blanz J, Schweizer M, Auberson M, Maier H, Muenscher A, Hübner CA and Jentsch TJ: Leukoencephalopathy upon disruption of the chloride channel ClC-2. J Neurosci. 27:6581–6589. 2007. View Article : Google Scholar : PubMed/NCBI

36 

He F, Peng Y, Yang Z, Ge Z, Tian Y, Ma T and Li H: Activated ClC-2 inhibits p-Akt to repress myelination in GDM newborn rats. Int J Biol Sci. 13:179–188. 2017. View Article : Google Scholar : PubMed/NCBI

37 

Guo R, Pan F, Tian Y, Li H, Li S and Cao C: Down-regulation of ClC-3 expression reduces epidermal stem cell migration by inhibiting volume-activated chloride currents. J Membr Biol. 249:281–292. 2016. View Article : Google Scholar : PubMed/NCBI

38 

Klaus F, Laufer J, Czarkowski K, Strutz-Seebohm N, Seebohm G and Lang F: PIKfyve-dependent regulation of the Cl-channel ClC-2. Biochem Biophys Res Commun. 381:407–411. 2009. View Article : Google Scholar : PubMed/NCBI

39 

Palmada M, Dieter M, Boehmer C, Waldegger S and Lang F: Serum and glucocorticoid inducible kinases functionally regulate ClC-2 channels. Biochem Biophys Res Commun. 321:1001–1006. 2004. View Article : Google Scholar : PubMed/NCBI

40 

Makara JK, Rappert A, Matthias K, Steinhäuser C, Spät A and Kettenmann H: Astrocytes from mouse brain slices express ClC-2-mediated Cl-currents regulated during development and after injury. Mol Cell Neurosci. 23:521–530. 2003. View Article : Google Scholar : PubMed/NCBI

41 

Földy C, Lee SH, Morgan RJ and Soltesz I: Regulation of fast-spiking basket cell synapses by the chloride channel ClC-2. Nat Neurosci. 13:1047–1049. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hou X, Zhang R, Wang J, Li Y, Li F, Zhang Y, Zheng X, Shen Y, Wang Y, Zhou L, Zhou L, et al: CLC-2 is a positive modulator of oligodendrocyte precursor cell differentiation and myelination. Mol Med Rep 17: 4515-4523, 2018.
APA
Hou, X., Zhang, R., Wang, J., Li, Y., Li, F., Zhang, Y. ... Zhou, L. (2018). CLC-2 is a positive modulator of oligodendrocyte precursor cell differentiation and myelination. Molecular Medicine Reports, 17, 4515-4523. https://doi.org/10.3892/mmr.2018.8439
MLA
Hou, X., Zhang, R., Wang, J., Li, Y., Li, F., Zhang, Y., Zheng, X., Shen, Y., Wang, Y., Zhou, L."CLC-2 is a positive modulator of oligodendrocyte precursor cell differentiation and myelination". Molecular Medicine Reports 17.3 (2018): 4515-4523.
Chicago
Hou, X., Zhang, R., Wang, J., Li, Y., Li, F., Zhang, Y., Zheng, X., Shen, Y., Wang, Y., Zhou, L."CLC-2 is a positive modulator of oligodendrocyte precursor cell differentiation and myelination". Molecular Medicine Reports 17, no. 3 (2018): 4515-4523. https://doi.org/10.3892/mmr.2018.8439
Copy and paste a formatted citation
x
Spandidos Publications style
Hou X, Zhang R, Wang J, Li Y, Li F, Zhang Y, Zheng X, Shen Y, Wang Y, Zhou L, Zhou L, et al: CLC-2 is a positive modulator of oligodendrocyte precursor cell differentiation and myelination. Mol Med Rep 17: 4515-4523, 2018.
APA
Hou, X., Zhang, R., Wang, J., Li, Y., Li, F., Zhang, Y. ... Zhou, L. (2018). CLC-2 is a positive modulator of oligodendrocyte precursor cell differentiation and myelination. Molecular Medicine Reports, 17, 4515-4523. https://doi.org/10.3892/mmr.2018.8439
MLA
Hou, X., Zhang, R., Wang, J., Li, Y., Li, F., Zhang, Y., Zheng, X., Shen, Y., Wang, Y., Zhou, L."CLC-2 is a positive modulator of oligodendrocyte precursor cell differentiation and myelination". Molecular Medicine Reports 17.3 (2018): 4515-4523.
Chicago
Hou, X., Zhang, R., Wang, J., Li, Y., Li, F., Zhang, Y., Zheng, X., Shen, Y., Wang, Y., Zhou, L."CLC-2 is a positive modulator of oligodendrocyte precursor cell differentiation and myelination". Molecular Medicine Reports 17, no. 3 (2018): 4515-4523. https://doi.org/10.3892/mmr.2018.8439
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team